Jump to content

EME (psychedelic)

From Wikipedia, the free encyclopedia
EME
Names
Preferred IUPAC name
1-(2,5-Diethoxy-4-methoxyphenyl)propan-2-amine
Identifiers
3D model (JSmol)
ChemSpider
UNII
  • InChI=1S/C14H23NO3/c1-5-17-12-9-13(16-4)14(18-6-2)8-11(12)7-10(3)15/h8-10H,5-7,15H2,1-4H3 checkY
    Key: IVHFHHXLFFHTTA-UHFFFAOYSA-N checkY
  • InChI=1/C14H23NO3/c1-5-17-12-9-13(16-4)14(18-6-2)8-11(12)7-10(3)15/h8-10H,5-7,15H2,1-4H3
    Key: IVHFHHXLFFHTTA-UHFFFAOYAT
  • C1(=CC(=C(C=C1CC(C)N)OCC)OC)OCC
  • COc1cc(OCC)c(cc1OCC)CC(C)N
Properties
C14H23NO3
Molar mass 253.342 g·mol−1
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
checkY verify (what is checkY☒N ?)

EME (2,5-diethoxy-4-methoxyamphetamine) is a lesser-known psychedelic drug. It is a diethoxy-methoxy analog of TMA-2. EME was first synthesized by Alexander Shulgin. In his book PiHKAL, both the dosage and duration are unknown.[1] EME produces few to no effects. Very little data exists about the pharmacological properties, metabolism, and toxicity of EME.

See also

[edit]

References

[edit]